摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

sodium fluoroacetate | 62-74-8

中文名称
——
中文别名
——
英文名称
sodium fluoroacetate
英文别名
sodium 2-fluoroacetate;sodium monofluoroacetate;fluoroacetic acid sodium salt;sodium;2-fluoroacetate
sodium fluoroacetate化学式
CAS
62-74-8
化学式
C2H2FO2*Na
mdl
——
分子量
100.025
InChiKey
JGFYQVQAXANWJU-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 稳定性/保质期:
    工业品带有微弱的醋酸酯气味,在空气中容易吸湿并变得黏稠。急性口服LD₅₀(mg/kg):褐家鼠0.22,小家鼠8.0,长爪沙鼠0.65,狗0.06。毒饵使用浓度为0.1%~0.3%。由于其对人和动物的毒性极大、药效迅速且具有二次毒性,中国已明确禁止生产和使用此物质。

计算性质

  • 辛醇/水分配系数(LogP):
    -4.29
  • 重原子数:
    6
  • 可旋转键数:
    1
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    40.1
  • 氢给体数:
    0
  • 氢受体数:
    3

ADMET

代谢
在向大鼠注射了含有放射性碳-14的氟代醋酸后,大约3%的放射性标记在4天内出现在呼吸二氧化碳中,32%出现在尿液中。从尿液中回收到了标记的氟柠檬酸盐。标签被证明已经整合到胆固醇以及较低和较高脂肪酸部分中。还观察到了其他未识别的标记物质。
Following injection of fluoroacetate-2-(14)C into rats, about 3% of label appeared in respiratory carbon dioxide and 32% in urine within 4 days. Labeled fluorocitrate was recovered from urine. Incorporation of label into cholesterol and into... lower and higher fatty acid fractions was demonstrated. Other unidentified labeled materials /were/... observed.
来源:Hazardous Substances Data Bank (HSDB)
代谢
当应用了含有放射性碳-14的氟代醋酸盐到植物(相思树、蓖麻、花生、斑豆)上时,观察到了标记的 carbon monoxide。一些标记碳也被结合进入了水溶性组分和脂质中。在一些植物种子中,它被转化为了含有氟的长链脂肪酸。
When fluoroacetate-2-(14)C was applied to plants (acacia geoginae, castor bean, peanut, pinto bean), labeled carbon monoxide was observed. Some label... was also incorporated into water soluble fractions and lipids. In some plant seeds... /it/ was converted into fluorine-containing long chain fatty acids.
来源:Hazardous Substances Data Bank (HSDB)
代谢
氟乙酸钠在体内转化为氟柠檬酸,通过抑制顺乌头酸酶活性来阻断三羧酸循环。可以通过检测所有器官中柠檬酸水平的升高或通过测定顺乌头酸酶活性来诊断中毒。
Sodium fluoroacetate is converted into fluorocitric acid in body and blocks TCA cycle by inhibiting aconitase activity. Poisoning can be diagnosed by increased citric acid levels in all organs or by determination of aconitase activity.
来源:Hazardous Substances Data Bank (HSDB)
代谢
2,4-二硝基氟苯与谷胱甘肽反应,形成一种类似于模型谷胱甘肽-S-转移酶底物1-氯-2,4-二硝基苯的稳定产物。...氟乙酰胺与氟乙酸一样,没有可察觉的化学去氟作用。其酶促去氟作用约为氟乙酸的10%,仅为2,4-二硝基氟苯的0.2%。针对氟乙酸特异性脱卤酶的抗体沉淀了氟乙酸和氟乙酰胺的去氟活性,但对1-氯-2,4-二硝基苯或2,4-二硝基氟苯的活性没有影响。...2,4-二硝基氟苯由谷胱甘肽-S-转移酶代谢,而氟乙酰胺由氟乙酸特异性脱卤酶代谢。
2,4-Dinitrofluorobenzene reacts with glutathione to form a stable product similar to that formed with the model glutathione-S-transferase substrate, 1-chloro-2,4-dinitrobenzene. ... Fluoroacetamide, like fluoroacetate, undergoes no discernable chemical defluorination. Its enzymatic defluorination is approx 10% of that observed for fluoroacetate and only 0.2% of the rate for 2,4-dinitrofluorobenzene. An antibody raised to the fluoroacetate specific dehalogenase precipitated both fluoroacetate ad fluoroacetamide defluorinating activity but had no effect on either 1-chloro-2,4-dinitrobenzene or 2,4-dinitrofluorobenzene activity. ... 2,4-Dinitrofluorobenzene is metabolized by the glutathione-S-transferase while fluoroacetamide is metabolized by the fluoroacetate specific dehalogenase.
来源:Hazardous Substances Data Bank (HSDB)
代谢
氟乙酸盐通过腹腔注射给大鼠和小鼠后,会被脱氟生成氟离子,这在尿液和肾脏中通过^19F NMR检测到。使用^13C标记的2-、1,2-氟乙酸盐和^14C标记的1,2-氟乙酸盐...揭示了尿液中存在复杂的代谢物混合物,包括在大鼠和小鼠中的S-(羧甲基)结合复合物以及在大鼠中的亚磺酰化产物...。...在用^13C标记的氟乙酸盐处理后,胆汁中显示出S-(羧甲基)谷胱甘肽或相关结合物以及氟乙酸盐的O-结合物的存在。将^13C标记的氟乙酸盐与大鼠和小鼠肝脏细胞溶质一起培养,涉及到S-((^13C-羧甲基))谷胱甘肽和氟离子的形成。氟柠檬酸盐也在小鼠肝脏细胞溶质与氟乙酸盐的培养中被检测到。氟乙酰胺通过腹腔注射给大鼠和小鼠后,会通过一种对有机磷酸盐敏感的酰胺酶的水解作用释放出氟乙酸盐,进而形成尿液中的氟离子。(^19)F NMR...的其他氟乙酰胺代谢物与小鼠肝脏中的氟乙酰羟胺酸和大鼠尿液中的氟柠檬酸盐一致。氟乙醇在大鼠和小鼠中产生尿液中的氟乙酸盐和氟离子,并且通过小鼠和大鼠肝脏微粒体转化为氟乙醛。(-)-和(+)-苏式-氟柠檬酸盐通过腹腔注射给大鼠后,在6小时内主要产生原始化合物在尿液中,此后氟离子的量逐渐增加。...大鼠和小鼠肝脏细胞溶质脱氟(-)-苏式-氟柠檬酸盐。代谢脱氟和猪心草酸酶也能脱氟(-)-苏式-氟柠檬酸盐。因此,氟乙酸盐及其前体氟乙酰胺和氟乙醇的代谢脱氟可归因于氟乙酸盐与谷胱甘肽的结合以及转化为(-)-苏式-氟柠檬酸盐,后者既是草酸酶的抑制剂也是其底物。...用氟乙酸盐或(-)-苏式-氟柠檬酸盐中毒的大鼠和小鼠的尿液中,柠檬酸盐和葡萄糖升高,尿素降低,这与三羧酸循环和氨代谢的干扰一致。
Fluoroacetate administered ip to rats and mice is defluorinated to give fluoride ion evident in urine and kidney by (19)F NMR. The use of 2-(13)C-, 1,2-(13)C-, and 1,2-(14)C-fluoroacetate, ... reveals a complex mixture of urinary metabolites including an S-(carboxymethyl) conjugate complex in rats and mice and sulfoxidation products... in rats. ...Bile, following treatment with 2-(13)C- fluoroacetate, shows the presence of S-(carboxymethyl)glutathione or a related conjugate and an O-conjugate of fluoroacetate. Incubation of (13)C-fluoroacetate with rat and mouse liver cytosol involves formation of S-((13)C-carboxymethyl) glutathione and fluoride ion. Fluorocitrate is also /detected in/ fluoroacetate incubations with mouse liver cytosol. Fluoroacetamide administered ip to rats and mice yields urinary fluoride ion formed via fluoroacetate which is liberated on hydrolysis by an organophosphate-sensitive amidase. (19)F NMR... of other metabolites of fluoroacetamide are consistent with fluoroacetohydroxamic acid in the liver of mice and fluorocitrate in the urine of rats. Fluoroethanol gives urinary fluoroacetate and fluoride ion in rats and mice and is converted to fluoroacetaldehyde by mouse and rat liver microsomes. (-)- and (+)-erythro- fluorocitrates administered ip to rats yield mostly the parent compounds in urine at 6 hr with increasing amounts of fluoride ion thereafter. ...Rat and mouse liver cytosols defluorinate (-)-erythro-fluorocitrate. Metabolic defluorination and pig heart aconitase also defluorinates (-)-erythro- fluorocitrate. Metabolic defluorination of fluoroacetate and its progenitors, fluoroacetamide and fluoroethanol, is therefore attributable to both conjugation of fluoroacetate with glutathione and conversion to (-)-erythro-fluorocitrate, which is both an inhibitor of and a substrate for aconitase. ...Urine of rats and mice poisoned with fluoroacetate or (-)-erythro-fluorocitrate show elevated citrate and glucose and diminished urea consistent with disruptions in the tricarboxylic acid cycle and ammonia metabolism.
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 致癌性证据
未列出
Not listed
来源:Occupational Safety and Health Administration (OSHA)
毒理性
  • 健康影响
健康影响代码:HE4 - 急性毒性 - 短期高风险效应
Health Effect Code(s):HE4 - Acute Toxicity---Short-term high risk effects
来源:Occupational Safety and Health Administration (OSHA)
毒理性
  • 暴露途径
这种物质可以通过吸入、皮肤接触和摄入被身体吸收。
The substance can be absorbed into the body by inhalation, through the skin and by ingestion.
来源:ILO International Chemical Safety Cards (ICSC)
毒理性
  • 暴露途径
吸入,皮肤吸收,吞食,皮肤和/或眼睛接触
inhalation, skin absorption, ingestion, skin and/or eye contact
来源:The National Institute for Occupational Safety and Health (NIOSH)
毒理性
  • 症状
呕吐;焦虑,幻听;面部感觉异常;面部肌肉抽搐;交替脉,心律不齐,心动过速,心脏节律失常;肺水肿;眼球震颤;抽搐;肝脏、肾脏损害
vomiting; anxiety, auditory hallucinations; facial paresthesia; twitching face muscle; pulsus altenans, ectopic heartbeat, tachycardia, cardiac arrhythmias; pulmonary edema; nystagmus; convulsions; liver, kidney damage
来源:The National Institute for Occupational Safety and Health (NIOSH)
吸收、分配和排泄
... 快速被胃肠道吸收。完整皮肤对其吸收不佳,但在皮炎或其他皮肤损伤的情况下,吸收可能会增加。
... Rapidly absorbed by GI tract. It is not well absorbed by intact skin, but absorption may be greater in presence of dermatitis or other skin injury.
来源:Hazardous Substances Data Bank (HSDB)
吸收、分配和排泄
... 取自尸检的样本,该男子在被发现昏迷后大约存活了17小时 ... 尿液中浓度为368 ppm;肝脏中为58 ppm;大脑中为76 ppm;肾脏中为65 ppm。
... Samples taken at autopsy from man who survived about 17 hours after being found unconscious ... /showed concn in/ urine, 368 ppm; liver, 58 ppm; brain, 76 ppm; and kidney, 65 ppm.
来源:Hazardous Substances Data Bank (HSDB)
吸收、分配和排泄
...死因被怀疑是氟乙酸钠导致的人体内脏含有2.4毫克/100克的氟。
...Liver of person whose death was supposed due to sodium fluoroacetate contained 2.4 mg of fluorine/100 g.
来源:Hazardous Substances Data Bank (HSDB)
吸收、分配和排泄
从大脑中每单位组织重量回收的氟乙酸钠的量是其他器官的两倍,这是在兔子服用10倍LD50剂量的毒药后被杀死的。有机氟化物的量在大约24小时后与刚死亡时大致相同,并且逐渐减少,三天后减少了10-20%,当尸体在21-25°C保存时,减少了50-80%。
Amount of sodium monofluoroacetate recovered from brain per unit weight of tissue was about 2 times that from other organs after rabbits were killed with dose 10 times LD50. Amount of organofluorine was about the same 24 hr after death as immediately after death and decreased gradually, by 10-20% after 3 days and by 50-80% when carcass was kept at 21-25 °C.
来源:Hazardous Substances Data Bank (HSDB)

制备方法与用途

制备方法

由氯乙酸甲酯与氟化氢加压反应生成氟乙酸甲酯,再进行碱解而成。

合成制备方法

同样由氯乙酸甲酯与氟化氢在加压条件下反应生成氟乙酸甲酯,随后通过碱解步骤完成合成。

用途简介

主要用于氟化物的合成。

用途

主要应用于氟化物的合成。

反应信息

  • 作为反应物:
    描述:
    sodium fluoroacetate盐酸 作用下, 以 为溶剂, 以5.0 g的产率得到氟乙酸
    参考文献:
    名称:
    银催化杂芳烃与α-氟代羧酸的单氟烷基化:溶剂效应的洞察
    摘要:
    已经开发了一种温和有效的方法,用于用易于获得且廉价的 α-氟羧酸直接 C-H 单氟烷基化杂芳烃。这种银催化的反应在温和条件下以良好的收率提供单和双单氟烷基化杂芳烃,并详细讨论了溶剂对单氟烷基化反应的影响。
    DOI:
    10.1039/d1cc06466e
  • 作为产物:
    描述:
    氟乙酸甲酯 在 sodium hydroxide 作用下, 以 四氢呋喃 为溶剂, 反应 2.0h, 以94%的产率得到sodium fluoroacetate
    参考文献:
    名称:
    Mechanistic Insights of a Concerted Metalation–Deprotonation Reaction with [Cp*RhCl2]2
    摘要:
    The effect of the carboxylate used in a concerted metalation-deprotonation reaction is probed, and shows a direct correlation of pK(a) to observed rate up to a pK(a) of 4.3, Where the rate drops off at higher pK(a). The rate of the C-H antivation of 2-(4-methoxyphenyl)pyridine with [Cp*RhCl2](2) and carboxylate follows first-order kinetics hi the active metal species, Cp*RhCl(kappa(2)-OAc), and zero-Order kinetics in substrate when in a 1:1 ratio. There is a first-order dependence on substrate observed when excess substrate is present. The evaluation of the mechanism using kinetic studies allowed for a mechanistic proposal in which a second Ph'Py coordinates prior to the rate-determining C-H activation.
    DOI:
    10.1021/acs.organomet.5b00369
  • 作为试剂:
    描述:
    氟乙酸酐间硝基苯甲醛sodium fluoroacetate 作用下, 生成 2-fluoro-3-hydroxy-2-(α-hydroxy-3-nitro-benzyl)-3-(3-nitro-phenyl)-propionic acid
    参考文献:
    名称:
    305.有机氟化合物。第七部分 珀金及与氟乙酸的类似反应
    摘要:
    DOI:
    10.1039/jr9560001524
点击查看最新优质反应信息

文献信息

  • [EN] METHODS OF TREATMENT OF AMYLOIDOSIS USING ASPARTYL-PROTEASE INIHIBITORS<br/>[FR] PROCEDES DE TRAITEMENT D'AMYLOIDOSE UTILISANT DES INHIBITEURS DE PROTEASE ASPARTYLE
    申请人:ELAN PHARM INC
    公开号:WO2005070407A1
    公开(公告)日:2005-08-04
    The invention relates to acetyl 2-hydroxy-1,3-diaminospirocyclohexanes and derivatives thereof that are useful in treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
    这项发明涉及乙酰2-羟基-1,3-二氨基螺环己烷及其衍生物,可用于治疗与淀粉样变性相关的疾病、疾病和症状。淀粉样变性是指与A-beta蛋白异常沉积相关的一系列疾病、疾病和症状。
  • Methods of treatment of amyloidosis using bi-aryl aspartyl protease inhibitors
    申请人:John Varghese
    公开号:US20060014737A1
    公开(公告)日:2006-01-19
    The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
    这项发明涉及新型化合物和治疗与淀粉样变性相关的疾病、紊乱和症状的方法。淀粉样变性指与A-beta蛋白异常沉积相关的一系列疾病、紊乱和症状。
  • The Sensitive Balance between Five-Coordinate Carbene and Six-Coordinate Carbyne Ruthenium Complexes Formed from Ruthenium Vinylidene Precursors
    作者:Pablo González-Herrero、Birgit Weberndörfer、Kerstin Ilg、Justin Wolf、Helmut Werner
    DOI:10.1021/om010422x
    日期:2001.8.1
    carbene complexes [Ru(κ2-O2CR1)C(CH2Ph)OC(O)R2}(PiPr3)2]BArf [R1 = R2 = CHF2 (7a), CF3 (7b); R1 = CF3, R2 = H (7c)] were obtained on protonation of the precursors [Ru(κ1-O2CR1)(κ2-O2CR2)(CCHPh)(PiPr3)2] (4a−c) with [H(OEt2)2]BArf. Both 7a and 7b undergo a fluxional process in solution resulting in a κ1/κ2 interconversion of the carboxylato groups. The crystal and molecular structures of 2b, 5e, and 6a
    二氯(亚乙烯基)钌化合物[RuCl 2(C CHR)L 2 ](R = Ph或t Bu和L = PCy 3或P i Pr 3)(1a - d)与[H(OEt 2)2 ] BAR ˚F(巴˚F - = [B C 6 H ^ 3(CF 3)2 -3,5} 4 ] - )导致质子的在C攻击β亚乙烯基配体的碳原子,并以几乎定量的产率得到相应的阳离子,五配位碳氮鎓络合物[RuCl 2(⋮CCH 2 R)L 2 ] BAr f(2a - d)。所述羧酸根衍生物将[RuCl(κ的质子化2 -O 2 CR)(Ç CHPh配合)(P我镨3)2 ] [R = H(图3a),CH 3(图3b),或PH(3F)]与[ H(OET 2)2 ] BAR ˚F导致形成五配位环状卡宾配合物[RuCl C(CH 2 Ph)OC(O)R}(P i Pr 3)2 ] BAr f [R = H(6a),CH 3(6b) ,
  • β-Haloethanol Substrates as Probes for Radical Mechanisms for Galactose Oxidase
    作者:Rebekka M. Wachter、Michael P. Montague-Smith、Bruce P. Branchaud
    DOI:10.1021/ja9626695
    日期:1997.8.1
    Ketyl radical anions with a halogen substitutent on the carbon adjacent to ketyl are known to rapidly rearrange by halide anion ejection. Such a rearrangement is an ideal probe for possible ketyl radical anion intermediates in the catalytic mechanism of the monocopper/tyrosine radical enzyme galactose oxidase (GOase). Turnover of β-fluoro-, β-chloro-, β-bromo-, and β-iodoethanol by GOase leads to mechanism-based
    已知在与羰基相邻的碳上具有卤素取代基的羰基自由基阴离子通过卤化物阴离子喷射快速重排。这种重排是单铜/酪氨酸自由基酶半乳糖氧化酶 (GOase) 催化机制中可能的酮基阴离子中间体的理想探针。GOase 对 β-氟-、β-氯-、β-溴-和 β-碘乙醇的转化,通过将酶捕获在催化失活的单电子还原形式中,导致酶的基于机制的失活。假设基于机制的失活和周转通过相同的反应中间体进行,此处报告的数据将底物氧化步骤(从底物到酶的两个电子转移)的可能机制缩小到两种相似的可能性。
  • Crystal Structure and Spectroscopic Investigation of Bromofluoro‐ and Fluoroiodomethane
    作者:Michael Feller、Karin Lux、Andreas Kornath
    DOI:10.1002/ejic.201500759
    日期:2015.11
    The solid states of bromofluoromethane (BFM) and fluoroiodomethane (FIM) are characterized by X-ray diffraction analysis and by Raman spectroscopy. The single crystals were obtained by crystallization in situ at low temperature. BFM and FIM crystallize in the space group I2/a and Abm2, respectively. The Raman spectra of both compounds were recorded in different aggregation states and at different temperatures
    溴氟甲烷 (BFM) 和氟碘甲烷 (FIM) 的固态通过 X 射线衍射分析和拉曼光谱进行表征。通过在低温下原位结晶获得单晶。BFM 和 FIM 分别在空间群 I2/a 和 Abm2 中结晶。在不同的聚集状态和不同的温度下记录了两种化合物的拉曼光谱。量子化学计算和 X 射线衍射数据被认为可以描述两种化合物在固态下的非共价相互作用。这些相互作用是在 σ-hole 概念的上下文中讨论的。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
hnmr
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物